New safety warnings also added to all prescription opioid medications to inform prescribers and patients of additional risks related to opioid use
Silver Spring, Maryland–(ENEWSPF)–March 22, 2016. In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about…
